Other languages Toleranzia AB

Equities

TOL

SE0007438577

Market Closed - Nasdaq Stockholm Other stock markets 11:22:27 2024-05-02 am EDT			5-day change	1st Jan Change
0.54 ^SEK	+4.25%		+5.88%	+26.17%

Feb. 23	Toleranzia AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
Feb. 23	Toleranzia AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Toleranzia AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 23
Toleranzia AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23
Toleranzia AB Successfully Completes GLP Toxicology Study of TOL2	Jan. 15
Toleranzia AB Starts Production of Completed Drug Product for Clinical Studies	Dec. 21
Toleranzia AB Announces Nomination Committee	Dec. 15
Toleranzia AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-27
Toleranzia AB Starts Toxicology Study of its Lead Drug Candidate TOL2	23-09-26
Toleranzia AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-25
Toleranzia AB Establishes a Freeze-Dried Formulation of the TOL2 Drug Product	23-08-24
Toleranzia AB Run GMP Manufacturing of Drug Candidate Tol2 for Clinical Study	23-08-21
Toleranzia AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-03
Toleranzia AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-24
Toleranzia AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-24
Toleranzia AB Announces Appointment of Nomination Committee	23-01-12
Toleranzia AB Announces Successful Large-Scale Production of Drug Candidate TOL2	22-12-01
Toleranzia AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-28
Toleranzia AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26
Toleranzia AB Announces Positive Results for Toleranzia's Drug Candidate ToL2 Published in Reputable Scientific Journal	22-06-03
Toleranzia AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-06
Toleranzia AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Toleranzia AB

Equities

TOL

SE0007438577

Other languages

Filters